Apellis Pharmaceuticals, Inc. (APLS) by event type

APLS moves most on analyst upgrades — a median of +1.52% at 30 minutes across 19 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the APLS overview →

By event type

How APLS reacts across 6 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
62 of 2,717
19+1.52%63%+1.13%
Analyst downgrades
1,035 of 2,603
40+0.09%85%+0.07%
Coverage initiations
775 of 2,283
32+0.17%59%-0.47%
Rating reiterations
3,146 of 3,522
146-0.32%38%-0.09%
Price-target raises
123 of 1,790
34+0.30%56%+0.30%
Price-target cuts
1,430 of 1,527
51-0.42%35%-0.30%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.

That’s how APLS usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · APLS overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
ESSA Pharma Inc. (EPIX)7180.00%38%
Tricida, Inc. (TCDA)715+0.06%51%
Enochian Biosciences, Inc. (ENOB)7120.00%42%
LIFEPOINT HEALTH INC COMMON (LPNT)709+0.01%51%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.